Endpoints News 2025-12-19 Senators point fingers over who blocked the rare disease voucher reauthorization
Endpoints News 2025-12-18 Daiichi and Merck's I-Dxd lung cancer study faces partial hold due to deaths
Endpoints News 2025-12-18 After year of triumph, Insmed stumbles with chronic rhinosinusitis fail, brings in new asset
Endpoints News 2025-12-18 Lilly’s orforglipron is the first oral obesity therapy to show its worth in the maintenance setting